Clinical Trial Update: Multi-Center Study Evaluating the Efficacy of Wobenzym(R)N in Treating Knee Osteoarthritis [Phase 2, Phase 3]

View source ↗

Summary

The multi-center Phase 2/3 trial evaluating Wobenzym N for knee osteoarthritis has been withdrawn. No results or further status details are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Wobenzym N

Snippet

Sponsor: Atrium Innovations | Conditions: Knee Osteoarthritis | Phase 2, Phase 3 | Status: WITHDRAWN